Ali Saberi Shahrbabaki
Overview
Explore the profile of Ali Saberi Shahrbabaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Asgarzadeh S, Ebadi A, Shahrbabaki A, Safari S, Aghili S, Farhang Ranjbar M, et al.
Arch Acad Emerg Med
. 2023 Nov;
12(1):e1.
PMID: 38022714
Introduction: Overcrowding in emergency departments (ED) is a global concern, emphasizing the need for effective resource allocation. Triage plays a crucial role in prioritizing patients based on medical needs. This...
2.
Hajsadeghi S, Mesgarha M, Mohammad A, Shahrbabaki A, Talebi A
Toxicol Rep
. 2022 Dec;
9:848-851.
PMID: 36561946
Metformin is a widely used anti-hyperglycemic agent with weight loss effect properties but besides its various utilities, despite being very rare, it has its characteristic toxicity and adverse effects when...
3.
Zeraatian Nejad Davani S, Mesgarha M, Talebi A, Shahrbabaki A, Mohammad A, Shafikhani Y
Int J Surg Case Rep
. 2022 Aug;
98:107526.
PMID: 35988503
Introduction And Importance: Despite the increasing number of liver and kidney transplants, the number of patients awaiting for a proper donor is still exceeding. Therefore, the preservation of donor organs...
4.
Ramezani M, Zeinaddini Meymand A, Khodagholi F, Mohammadi Kamsorkh H, Asadi E, Noori M, et al.
Nutr Neurosci
. 2022 Feb;
26(2):156-172.
PMID: 35152858
Objective: Natural food substances, due to high rates of antioxidants, antiviral and anti-inflammatory properties, have been proposed to have the potential for the prevention or treatment of cognitive deficits, learning...
5.
Alirezaei T, Mahboubi-Fooladi Z, Irilouzadian R, Shahrbabaki A, Golestani H
Clin Cardiol
. 2022 Feb;
45(2):224-230.
PMID: 35132667
Background: Accurate risk stratification is the most important step in the management of patients with acute pulmonary thromboembolism (PTE). Pulmonary embolism severity index (PESI) is a clinical tool for PTE...
6.
Talebi A, Zeraatian Nejad Davani S, Shahrbabaki A, Mesgarha M, Mohammad A, Zare-Mirzaie A
J Card Surg
. 2021 Dec;
37(3):688-692.
PMID: 34953076
Cardiac angiofibroma is a very rare diagnosis when a patient develops an intracardiac mass. It is a primary benign cardiac tumor with a scarcity of information in the literature. This...